These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 37567170)

  • 21. The antitumor effect of metformin with and without carboplatin on primary endometrioid endometrial carcinoma in vivo.
    Schrauwen S; Coenegrachts L; Cattaneo A; Hermans E; Lambrechts D; Amant F
    Gynecol Oncol; 2015 Aug; 138(2):378-82. PubMed ID: 26050920
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PIK3R1 (p85α) is somatically mutated at high frequency in primary endometrial cancer.
    Urick ME; Rudd ML; Godwin AK; Sgroi D; Merino M; Bell DW
    Cancer Res; 2011 Jun; 71(12):4061-7. PubMed ID: 21478295
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The expression of S100P increases and promotes cellular proliferation by increasing nuclear translocation of β-catenin in endometrial cancer.
    Guo L; Chen S; Jiang H; Huang J; Jin W; Yao S
    Int J Clin Exp Pathol; 2014; 7(5):2102-12. PubMed ID: 24966918
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long non-coding RNA steroid receptor activator promotes the progression of endometrial cancer via Wnt/ β-catenin signaling pathway.
    Park SA; Kim LK; Kim YT; Heo TH; Kim HJ
    Int J Biol Sci; 2020; 16(1):99-115. PubMed ID: 31892849
    [No Abstract]   [Full Text] [Related]  

  • 25. Circ_0109046 promotes the malignancy of endometrial carcinoma cells through the microRNA-105/SOX9/Wnt/β-catenin axis.
    Li Y; Liu J; Piao J; Ou J; Zhu X
    IUBMB Life; 2021 Jan; 73(1):159-176. PubMed ID: 33220169
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improved risk assessment of endometrial cancer by combined analysis of MSI, PI3K-AKT, Wnt/β-catenin and P53 pathway activation.
    Nout RA; Bosse T; Creutzberg CL; Jürgenliemk-Schulz IM; Jobsen JJ; Lutgens LC; van der Steen-Banasik EM; van Eijk R; Ter Haar NT; Smit VT
    Gynecol Oncol; 2012 Sep; 126(3):466-73. PubMed ID: 22609107
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Role of CTNNB1 in Endometrial Cancer.
    Ledinek Ž; Sobočan M; Knez J
    Dis Markers; 2022; 2022():1442441. PubMed ID: 35531470
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical significance of CTNNB1 mutation and Wnt pathway activation in endometrioid endometrial carcinoma.
    Liu Y; Patel L; Mills GB; Lu KH; Sood AK; Ding L; Kucherlapati R; Mardis ER; Levine DA; Shmulevich I; Broaddus RR; Zhang W
    J Natl Cancer Inst; 2014 Sep; 106(9):. PubMed ID: 25214561
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metformin inhibits estrogen-dependent endometrial cancer cell growth by activating the AMPK-FOXO1 signal pathway.
    Zou J; Hong L; Luo C; Li Z; Zhu Y; Huang T; Zhang Y; Yuan H; Hu Y; Wen T; Zhuang W; Cai B; Zhang X; Huang J; Cheng J
    Cancer Sci; 2016 Dec; 107(12):1806-1817. PubMed ID: 27636742
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of NCAPG expression inactivates the Wnt/β-catenin signal to suppresses endometrial cancer cell growth in vitro.
    Liu C; Yan Y; Di F; Li W; Yin X; Dong L
    Environ Toxicol; 2021 Dec; 36(12):2512-2520. PubMed ID: 34480403
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Somatic FGF9 mutations in colorectal and endometrial carcinomas associated with membranous beta-catenin.
    Abdel-Rahman WM; Kalinina J; Shoman S; Eissa S; Ollikainen M; Elomaa O; Eliseenkova AV; Bützow R; Mohammadi M; Peltomäki P
    Hum Mutat; 2008 Mar; 29(3):390-7. PubMed ID: 18165946
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MicroRNA-29b Inhibits Angiogenesis by Targeting VEGFA through the MAPK/ERK and PI3K/Akt Signaling Pathways in Endometrial Carcinoma.
    Chen HX; Xu XX; Tan BZ; Zhang Z; Zhou XD
    Cell Physiol Biochem; 2017; 41(3):933-946. PubMed ID: 28222438
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ligand-activated peroxisome proliferator-activated receptor β/δ modulates human endometrial cancer cell survival.
    Ma JJ; Monsivais D; Dyson MT; Coon JS; Malpani S; Ono M; Zhao H; Xin H; Pavone ME; Kim JJ; Chakravarti D; Bulun SE
    Horm Cancer; 2013 Dec; 4(6):358-70. PubMed ID: 23943160
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metformin inhibits β-catenin phosphorylation on Ser-552 through an AMPK/PI3K/Akt pathway in colorectal cancer cells.
    Amable G; Martínez-León E; Picco ME; Di Siervi N; Davio C; Rozengurt E; Rey O
    Int J Biochem Cell Biol; 2019 Jul; 112():88-94. PubMed ID: 31082618
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of mammalian target of rapamycin with aggressive type II endometrial carcinomas and poor outcome: a potential target treatment.
    Peiró G; Peiró FM; Ortiz-Martínez F; Planelles M; Sánchez-Tejada L; Alenda C; Ceballos S; Sánchez-Payá J; Laforga JB
    Hum Pathol; 2013 Feb; 44(2):218-25. PubMed ID: 22955108
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Doxazosin and erlotinib have anticancer effects in the endometrial cancer cell and important roles in ERα and Wnt/β-catenin signaling pathways.
    Karaca B; Bakır E; Yerer MB; Cumaoğlu A; Hamurcu Z; Eken A
    J Biochem Mol Toxicol; 2021 Nov; 35(11):e22905. PubMed ID: 34463000
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High frequency of POLE mutations in synchronous endometrial and ovarian carcinoma.
    Ishikawa M; Nakayama K; Nakamura K; Ono R; Yamashita H; Ishibashi T; Minamoto T; Iida K; Razia S; Ishikawa N; Kyo S
    Hum Pathol; 2019 Mar; 85():92-100. PubMed ID: 30448219
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MicroRNA-381 inhibits cell proliferation and invasion in endometrial carcinoma by targeting the IGF-1R.
    Tu C; Wang F; Wan J
    Mol Med Rep; 2018 Mar; 17(3):4090-4098. PubMed ID: 29257334
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Another surprise from Metformin: novel mechanism of action via K-Ras influences endometrial cancer response to therapy.
    Iglesias DA; Yates MS; van der Hoeven D; Rodkey TL; Zhang Q; Co NN; Burzawa J; Chigurupati S; Celestino J; Bowser J; Broaddus R; Hancock JF; Schmandt R; Lu KH
    Mol Cancer Ther; 2013 Dec; 12(12):2847-56. PubMed ID: 24077915
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DLGAP5 knockdown inactivates the Wnt/β-catenin signal to repress endometrial cancer cell malignant activities.
    Chen R; Liu J; Hu J; Li C; Liu Y; Pan W
    Environ Toxicol; 2023 Mar; 38(3):685-693. PubMed ID: 36454672
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.